Milacron Common Stock to Move to OTC Trading

* Reuters is not responsible for the content in this press release.

Tue May 20, 2008 4:32pm EDT

Company Focuses on Building Long-Term Shareholder Value
CINCINNATI--(Business Wire)--
Milacron Inc. (NYSE: MZ), a leading global supplier of
plastics-processing technologies and industrial fluids, announced
today that its common stock will be quoted on over-the-counter markets
beginning Tuesday, May 27. The company expects its stock to continue
to be actively traded in one of the premium tiers of the Pink Sheets
and is taking appropriate steps to be quoted on the OTC Bulletin Board
as well. The move from the New York Stock Exchange to OTC markets is
due to the company's currently low market capitalization.

   "As we emphasized at our annual meeting of shareholders earlier
this month, our focus is on building long-term shareholder value,"
said Ronald D. Brown, Milacron chairman, president and chief executive
officer. "We continue to improve our operating results and dedicate
resources to developing new products, expanding in emerging growth
markets and reducing our fixed cost structure in North America and
Western Europe. We fully expect these investments to continue to build
shareholder value in the long run."

   The forward-looking statements above by their nature involve risks
and uncertainties that could significantly impact operations, markets,
products and expected results. For further information please refer to
the Cautionary Statement included in the company's most recent Form
10-Q on file with the Securities and Exchange Commission.

   First incorporated in 1884, Milacron is a leading global supplier
of plastics-processing technologies and industrial fluids, with major
manufacturing facilities in North America, Europe and Asia. For
further information, visit www.milacron.com or call Milacron's
toll-free investor line: (800) 909-6452.

Milacron Inc.
Al Beaupre, 513-487-5918
albert.beaupre@milacron.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.